{"id":539419,"date":"2021-09-17T07:03:07","date_gmt":"2021-09-17T11:03:07","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\/"},"modified":"2021-09-17T07:03:07","modified_gmt":"2021-09-17T11:03:07","slug":"trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\/","title":{"rendered":"Trevena to Present at the Oppenheimer 2021 Fall Healthcare Life Sciences &amp; MedTech Summit"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">CHESTERBROOK, Pa., Sept.  17, 2021  (GLOBE NEWSWIRE) &#8212; <strong>Trevena, Inc. (Nasdaq: TRVN)<\/strong>, a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that Carrie Bourdow, President and Chief Executive Officer of Trevena, will present at the Oppenheimer 2021 Fall Healthcare Life Sciences &amp; MedTech Summit being held virtually from September 20<sup>th<\/sup> \u2013 23<sup>rd<\/sup>.<\/p>\n<p>\n        <strong><br \/>\n          <em><br \/>\n            <u>Presentation<\/u><br \/>\n          <\/em><br \/>\n        <\/strong><br \/>\n        <strong><br \/>\n          <em><br \/>\n            <u> Details<\/u><br \/>\n          <\/em><br \/>\n        <\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;width:628;border-collapse:collapse\">\n<tr>\n<td> Date: <\/td>\n<td> Tuesday, September 21<sup>st<\/sup>, 2021 <\/td>\n<\/tr>\n<tr>\n<td> Time: <\/td>\n<td> 8:15 a.m. ET <\/td>\n<\/tr>\n<tr>\n<td> Presenter: <\/td>\n<td> Carrie Bourdow,\u00a0<em>President &amp; CEO<\/em><\/td>\n<\/tr>\n<tr>\n<td> Webcast: <\/td>\n<td>\n            <a href=\"https:\/\/linkprotect.cudasvc.com\/url?a=https%3a%2f%2fwsw.com%2fwebcast%2foppenheimer16%2ftrvn%2f2838334&amp;c=E,1,CN_WF7DpuiRlexRXKPOnM8XN7AeRtAYmegwn4mdB8p6niFRfpS3jGAGn1Z8fShHdPKBMSNa1xFaXcdRg19Zn088m81FbWSU2DTICChuaJ8bS5ho,&amp;typo=1\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n              <u>https:\/\/wsw.com\/webcast\/oppenheimer16\/trvn\/2838334<\/u><br \/>\n            <\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">A link to the webcast will be available on the Events page of the Investors section of the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aRygE7NV8iZikyb46FiTcOyYxkaOL0OUvvka0RDLyMk8d4JwZlPI8Pp0IyX8DFpy1bvKGDoiOjpbg5Lr3TSVprPqLYR-8qrDYwaKUZqOToSwjXkMtVq4HSlFQC9T238mqcx8nZ6R61ItKKXW9vDWUB_GcY0cWVmbzbCUcFn0xWZKWG0XxTO542iJhqfdsAioAsb-xDMKeNS8pFNXsv3mSg==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.trevena.com\/investors\/events-presentations\/ir-calendar<\/a>. A replay of the presentation will be archived on the website and available for approximately 30 days following the event.<\/p>\n<p align=\"justify\">Carrie Bourdow, President &amp; CEO and Barry Shin, Chief Financial Officer, will be scheduling virtual 1&#215;1 meetings and encourage investors to schedule a time during the conference. If you are interested in arranging a one-on-one meeting, please contact your Oppenheimer representative.<\/p>\n<p align=\"justify\">\n        <strong>About Trevena<\/strong>\n      <\/p>\n<p align=\"justify\">Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative medicines for patients with CNS disorders. The Company has one approved product in the United States, OLINVYK\u00ae (oliceridine) injection, indicated in adults for the management of acute pain severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate. The Company\u2019s novel pipeline is based on Nobel Prize winning research and includes four differentiated investigational drug candidates: TRV250 for the acute treatment of migraine, TRV734 for maintenance treatment of opioid use disorder, TRV045 for diabetic neuropathic pain and epilepsy, and TRV027 for acute respiratory distress syndrome and abnormal blood clotting in COVID-19 patients.<\/p>\n<p align=\"justify\">For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fyFDRiypotlUy6YDzJWS2aprnV4vll6lhW6O2s-gT_q4PPDUjplW6Gg--HvM-GCjN4Q09z6Q6cNNgI8LSXYVZN2qIgkPSAD9-3OdkJ9N_Zclt-qfBRjcmzm54TyyWgiiB64A9KRTcmT4-fCn0BZprzW1LAmiEKB5VeY392HY3Gu6ElnSlVsXCHhbeUT1K8IDIZUk9DxVnEglEn_K7BqyfJIrvm9_TknU7BBOovtWyKg=\" rel=\"nofollow noopener\" target=\"_blank\">www.Trevena.com<\/a>.<strong>\u00a0<\/strong><\/p>\n<p align=\"justify\">\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p align=\"justify\">Any statements in this press release about future expectations, plans and prospects for the Company, including statements about the Company\u2019s strategy, future operations, clinical development and trials of its therapeutic candidates, plans for potential future product candidates, commercialization of approved drug products and other statements containing the words \u201canticipate,\u201d \u201cbelieve,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cmay,\u201d \u201cmight,\u201d \u201cplan,\u201d \u201cobjective,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201csuggest,\u201d \u201ctarget,\u201d \u201cpotential,\u201d \u201cwill,\u201d \u201cwould,\u201d \u201ccould,\u201d \u201cshould,\u201d \u201ccontinue,\u201d \u201congoing,\u201d or the negative of these terms or similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the commercialization of any approved drug product, the status, timing, costs, results and interpretation of the Company\u2019s clinical trials or any future trials of any of the Company\u2019s investigational drug candidates; the uncertainties inherent in conducting clinical trials; expectations for regulatory interactions, submissions and approvals, including the Company\u2019s assessment of the discussions with the FDA or other regulatory agencies about any and all of its programs; uncertainties related to the commercialization of OLINVYK; available funding; uncertainties related to the Company\u2019s intellectual property; uncertainties related to the ongoing COVID-19 pandemic, other matters that could affect the availability or commercial potential of the Company\u2019s therapeutic candidates; and other factors discussed in the Risk Factors set forth in the Company\u2019s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission (SEC) and in other filings the Company makes with the SEC from time to time. In addition, the forward-looking statements included in this press release represent the Company\u2019s views only as of the date hereof. The Company anticipates that subsequent events and developments may cause the Company\u2019s views to change. However, while the Company may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so, except as may be required by law.<\/p>\n<p align=\"justify\">\n        <strong>For more information, please contact:<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Investor Contact:<\/strong>\n      <\/p>\n<p align=\"justify\">Dan Ferry<br \/>Managing Director<br \/>LifeSci Advisors, LLC<br \/>daniel@lifesciadvisors.com<br \/>(617) 430-7576<\/p>\n<p align=\"justify\">\n        <strong>PR &amp; Media Contact:<\/strong>\n      <\/p>\n<p>Sasha Bennett<br \/>Associate Vice President<br \/>Clyde Group<br \/>Sasha.Bennett@clydegroup.com<br \/>(239) 248-3409<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNzYwNyM0NDEwMDQyIzIwMDUwMzQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ODNmOWVmOTktNjFmOS00OGVmLWExNGQtOTllNjI5MGRjYjM5LTEwMTY2MDc=\/tiny\/Trevena-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CHESTERBROOK, Pa., Sept. 17, 2021 (GLOBE NEWSWIRE) &#8212; Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that Carrie Bourdow, President and Chief Executive Officer of Trevena, will present at the Oppenheimer 2021 Fall Healthcare Life Sciences &amp; MedTech Summit being held virtually from September 20th \u2013 23rd. Presentation Details Date: Tuesday, September 21st, 2021 Time: 8:15 a.m. ET Presenter: Carrie Bourdow,\u00a0President &amp; CEO Webcast: https:\/\/wsw.com\/webcast\/oppenheimer16\/trvn\/2838334 A link to the webcast will be available on the Events page of the Investors section of the Company\u2019s website at https:\/\/www.trevena.com\/investors\/events-presentations\/ir-calendar. A replay of the presentation will be archived on the website and available for approximately &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Trevena to Present at the Oppenheimer 2021 Fall Healthcare Life Sciences &amp; MedTech Summit&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-539419","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Trevena to Present at the Oppenheimer 2021 Fall Healthcare Life Sciences &amp; MedTech Summit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Trevena to Present at the Oppenheimer 2021 Fall Healthcare Life Sciences &amp; MedTech Summit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CHESTERBROOK, Pa., Sept. 17, 2021 (GLOBE NEWSWIRE) &#8212; Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that Carrie Bourdow, President and Chief Executive Officer of Trevena, will present at the Oppenheimer 2021 Fall Healthcare Life Sciences &amp; MedTech Summit being held virtually from September 20th \u2013 23rd. Presentation Details Date: Tuesday, September 21st, 2021 Time: 8:15 a.m. ET Presenter: Carrie Bourdow,\u00a0President &amp; CEO Webcast: https:\/\/wsw.com\/webcast\/oppenheimer16\/trvn\/2838334 A link to the webcast will be available on the Events page of the Investors section of the Company\u2019s website at https:\/\/www.trevena.com\/investors\/events-presentations\/ir-calendar. A replay of the presentation will be archived on the website and available for approximately &hellip; Continue reading &quot;Trevena to Present at the Oppenheimer 2021 Fall Healthcare Life Sciences &amp; MedTech Summit&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-17T11:03:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNzYwNyM0NDEwMDQyIzIwMDUwMzQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Trevena to Present at the Oppenheimer 2021 Fall Healthcare Life Sciences &amp; MedTech Summit\",\"datePublished\":\"2021-09-17T11:03:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\\\/\"},\"wordCount\":675,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNzYwNyM0NDEwMDQyIzIwMDUwMzQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\\\/\",\"name\":\"Trevena to Present at the Oppenheimer 2021 Fall Healthcare Life Sciences &amp; MedTech Summit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNzYwNyM0NDEwMDQyIzIwMDUwMzQ=\",\"datePublished\":\"2021-09-17T11:03:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNzYwNyM0NDEwMDQyIzIwMDUwMzQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNzYwNyM0NDEwMDQyIzIwMDUwMzQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Trevena to Present at the Oppenheimer 2021 Fall Healthcare Life Sciences &amp; MedTech Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Trevena to Present at the Oppenheimer 2021 Fall Healthcare Life Sciences &amp; MedTech Summit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\/","og_locale":"en_US","og_type":"article","og_title":"Trevena to Present at the Oppenheimer 2021 Fall Healthcare Life Sciences &amp; MedTech Summit - Market Newsdesk","og_description":"CHESTERBROOK, Pa., Sept. 17, 2021 (GLOBE NEWSWIRE) &#8212; Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that Carrie Bourdow, President and Chief Executive Officer of Trevena, will present at the Oppenheimer 2021 Fall Healthcare Life Sciences &amp; MedTech Summit being held virtually from September 20th \u2013 23rd. Presentation Details Date: Tuesday, September 21st, 2021 Time: 8:15 a.m. ET Presenter: Carrie Bourdow,\u00a0President &amp; CEO Webcast: https:\/\/wsw.com\/webcast\/oppenheimer16\/trvn\/2838334 A link to the webcast will be available on the Events page of the Investors section of the Company\u2019s website at https:\/\/www.trevena.com\/investors\/events-presentations\/ir-calendar. A replay of the presentation will be archived on the website and available for approximately &hellip; Continue reading \"Trevena to Present at the Oppenheimer 2021 Fall Healthcare Life Sciences &amp; MedTech Summit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-17T11:03:07+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNzYwNyM0NDEwMDQyIzIwMDUwMzQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Trevena to Present at the Oppenheimer 2021 Fall Healthcare Life Sciences &amp; MedTech Summit","datePublished":"2021-09-17T11:03:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\/"},"wordCount":675,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNzYwNyM0NDEwMDQyIzIwMDUwMzQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\/","name":"Trevena to Present at the Oppenheimer 2021 Fall Healthcare Life Sciences &amp; MedTech Summit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNzYwNyM0NDEwMDQyIzIwMDUwMzQ=","datePublished":"2021-09-17T11:03:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNzYwNyM0NDEwMDQyIzIwMDUwMzQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNzYwNyM0NDEwMDQyIzIwMDUwMzQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-present-at-the-oppenheimer-2021-fall-healthcare-life-sciences-medtech-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Trevena to Present at the Oppenheimer 2021 Fall Healthcare Life Sciences &amp; MedTech Summit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/539419","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=539419"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/539419\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=539419"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=539419"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=539419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}